Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jan;16(1):78-80.
doi: 10.1177/1932296820967004. Epub 2020 Oct 21.

Analysis of "Accuracy of a 14-Day Factory Calibrated Continuous Glucose Monitoring System With Advanced Algorithm in Pediatric and Adult Population With Diabetes"

Affiliations
Comment

Analysis of "Accuracy of a 14-Day Factory Calibrated Continuous Glucose Monitoring System With Advanced Algorithm in Pediatric and Adult Population With Diabetes"

Tejaswi Kompala et al. J Diabetes Sci Technol. 2022 Jan.

Abstract

In this study by Alva et al, accuracy of a second-generation factory calibrated continuous glucose monitoring system is evaluated. Compared to the first-generation FreeStyle Libre 14-day system (FSL), accuracy was improved throughout the 14-day wear period, including improved accuracy in hypoglycemia for adults and youth. The addition of optional real-time alerts for hypoglycemia and hyperglycemia as well as an integrated continuous glucose monitor (iCGM) designation by the FDA may further enable users to benefit from using CGM in real time, including in future automated insulin delivery systems. As CGM accuracy, affordability, and accessibility improve, we anticipate increased uptake of CGM by people on intensive insulin therapy, and also potential benefits and expansion into a broader patient population. There are growing opportunities to leverage cloud-connected CGM devices in the increasingly virtual, continuous telehealth-driven diabetes care model, which will require more focus on development and use of data interoperability standards.

Keywords: continuous glucose monitoring; diabetes mellitus; digital health; telehealth.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Tejaswi Kompala has received consulting fees from Lilly.

Aaron Neinstein has received research support from Cisco Systems, Inc.; has received consulting fees from Lilly, Nokia Growth Partners, Roche, Medtronic, and Grand Rounds; serves as advisor to Steady Health (received stock options); has received speaking honoraria from Academy Health and Symposia Medicus; has written for WebMD (receives compensation); and is a medical advisor and co-founder of Tidepool (for which he receives no compensation).

Comment on

References

    1. Abbott MediaRoom. New Real-World Data Show that Abbott’s FreeStyle Libre System Delivers Positive Health Outcomes for People with Type 1 and Type 2 Diabetes. Abbott MediaRoom. https://abbott.mediaroom.com/2020-02-20-New-Real-World-Data-Show-that-Ab.... Accessed August 27, 2020.
    1. Foster NC, Beck RW, Miller KM, et al.. State of type 1 diabetes management and outcomes from the T1D exchange in 2016-2018. Diabetes Technol Ther. 2019;21(2):66-72. - PMC - PubMed
    1. Peters AL, Ahmann AJ, Battelino T, et al.. Diabetes technology-continuous subcutaneous insulin infusion therapy and continuous glucose monitoring in adults: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(11):3922-3937. - PubMed
    1. American Diabetes Association. Diabetes technology: standards of medical care in diabetes—2020. Diabetes Care. 2020;43(suppl 1):s77-s88. - PubMed
    1. Tanenbaum ML, Hanes SJ, Miller KM, Naranjo D, Bensen R, Hood KK. Diabetes device use in adults with type 1 diabetes: barriers to uptake and potential intervention targets. Diabetes Care. 2017;40(2):181-187. - PMC - PubMed